• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Huntsman Announces Fourth Quarter 2025 Earnings

    2/17/26 4:15:00 PM ET
    $HUN
    Major Chemicals
    Industrials
    Get the next $HUN alert in real time by email

    Fourth Quarter Highlights

    • Fourth quarter 2025 net loss attributable to Huntsman of $96 million compared to a net loss of $141 million in the prior year period; fourth quarter 2025 diluted loss per share of $0.56 compared to diluted loss per share $0.82 in the prior year period.
    • Fourth quarter 2025 adjusted net loss attributable to Huntsman of $63 million compared to adjusted net loss of $43 million in the prior year period; fourth quarter 2025 adjusted diluted loss per share of $0.37 compared to adjusted diluted loss per share of $0.25 in the prior year period.
    • Fourth quarter 2025 adjusted EBITDA of $35 million compared to $71 million in the prior year period.
    • Fourth quarter 2025 net cash provided by operating activities from continuing operations was $77 million. Free cash flow from continuing operations was $20 million for the fourth quarter 2025 compared to free cash flow of $108 million in the prior year period.




    Three months ended



    Twelve months ended





    December 31,



    December 31,

    In millions, except per share amounts



    2025



    2024



    2025



    2024



















    Revenues



    $     1,355



    $     1,452



    $     5,683



    $     6,036



















    Net loss attributable to Huntsman Corporation



    $        (96)



    $       (141)



    $       (284)



    $       (189)

    Adjusted net loss(1)



    $        (63)



    $        (43)



    $       (121)



    $        (13)



















    Diluted loss per share



    $      (0.56)



    $      (0.82)



    $      (1.65)



    $      (1.10)

    Adjusted diluted loss per share(1)



    $      (0.37)



    $      (0.25)



    $      (0.70)



    $      (0.08)



















    Adjusted EBITDA(1)



    $          35



    $          71



    $        275



    $        414



















    Net cash provided by operating activities from continuing operations



    $          77



    $        159



    $        298



    $        285

    Free cash flow from continuing operations(2)



    $          20



    $        108



    $        125



    $        101



















    See end of press release for footnote explanations and reconciliations of non-GAAP measures.

















    THE WOODLANDS, Texas, Feb. 17, 2026 /PRNewswire/ -- Huntsman Corporation (NYSE:HUN) today reported fourth quarter 2025 results with revenues of $1,355 million, net loss attributable to Huntsman of $96 million, adjusted net loss attributable to Huntsman of $63 million and adjusted EBITDA of $35 million. 

    Peter R. Huntsman, Chairman, President, and CEO, commented:

    "During 2025, there was an exceptional amount of work accomplished by the Company in restructuring our business and generating cash despite the depressed level of earnings. We generated close to $300 million of cash flow from operations in 2025 and our 45% full year free cash flow conversion reflects timely, definitive decisions as we recognized the challenging market landscape early in the year. We remain confident that the economic cycle for chemicals will eventually improve in our core markets, though we recognize that meaningful changes may not occur in the immediate term. We are committed to maintaining a disciplined approach, prioritizing cash management, the balance sheet and controlling our fixed costs to ensure the Company is well-positioned when our markets improve."

    Segment Analysis for 4Q25 Compared to 4Q24

    Polyurethanes

    The decrease in revenues in our Polyurethanes segment for the three months ended December 31, 2025 compared to the same period of 2024 was primarily due to lower average selling prices, partially offset by higher sales volumes. MDI average selling prices decreased primarily due to less favorable supply and demand dynamics. Sales volumes increased in the Americas and Asia regions. The decrease in segment adjusted EBITDA was primarily due to lower MDI margins.

    Performance Products

    The decrease in revenues in our Performance Products segment for the three months ended December 31, 2025 compared to the same period of 2024 was primarily due to lower average selling prices. Average selling prices decreased primarily due to competitive pressures. Sales volumes were relatively stable. The decrease in segment adjusted EBITDA was primarily due to lower revenues and an unfavorable impact from reduced inventory, partially offset by lower fixed costs.

    Advanced Materials

    The decrease in revenues in our Advanced Materials segment for the three months ended December 31, 2025 compared to the same period of 2024 was primarily due to lower sales volumes, partially offset by higher average selling prices. Sales volumes decreased in our infrastructure coatings and general industry segments due to soft demand. Average selling prices increased primarily due to the positive impact of major foreign currency exchange rate movements against the U.S. dollar. Segment adjusted EBITDA was slightly lower primarily due to decreased sales volumes.

    Liquidity and Capital Resources

    During the three months ended December 31, 2025, our free cash flow from continuing operations was $20 million as compared to $108 million in the same period of 2024. As of December 31, 2025, we had approximately $1.3 billion of combined cash and unused borrowing capacity.

    During the three months ended December 31, 2025, we spent $57 million on capital expenditures from continuing operations as compared to $51 million in the same period of 2024. During 2026, we expect similar capital expenditure levels as to the 2025 year.

    Income Taxes

    In the fourth quarter of 2025, our effective tax rate was -1% and our adjusted effective tax rate was -14%.

    Earnings Conference Call Information

    We will hold a conference call to discuss our fourth quarter 2025 financial results on Wednesday, February 18, 2026, at 10:00 a.m. ET.

    Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=IMeg0PNW

    Participant dial-in numbers:

    Domestic callers:                     (877) 402-8037

    International callers:                (201) 378-4913

    The conference call will be accompanied by presentation slides that will be accessible via the webcast link and Huntsman's investor relations website, www.huntsman.com/investors. Upon conclusion of the call, the webcast replay will be accessible via Huntsman's website.

    Upcoming Conferences

    During the first quarter 2026, a member of management is expected to present at:

    Bank of America Securities 2026 Global Agriculture and Materials Conference, February 25, 2026  

    Alembic Materials and Industrials Conference, March 4-6, 2026

    A webcast of the presentation, if applicable, along with accompanying materials will be available at www.huntsman.com/investors.

     

    Table 1 – Results of Operations















    Three months ended



    Twelve months ended





    December 31,



    December 31,

    In millions, except per share amounts



    2025



    2024



    2025



    2024



















    Revenues



    $     1,355



    $     1,452



    $     5,683



    $     6,036

    Cost of goods sold



    1,191



    1,264



    4,932



    5,170

    Gross profit



    164



    188



    751



    866

    Operating expenses:

















    Selling, general and administrative



    181



    166



    670



    671

    Research and development



    26



    30



    120



    121

    Restructuring, impairment and plant closing costs



    11



    19



    148



    39

    Income associated with litigation matter, net



    -



    -



    (33)



    -

    Gain on acquisition of assets, net



    -



    -



    (5)



    (51)

    Prepaid asset write-off



    -



    -



    -



    71

    Loss on dissolution of subsidiaries



    -



    39



    -



    39

    Other operating expense (income), net



    5



    (3)



    (18)



    1

    Total operating expenses



    223



    251



    882



    891

    Operating loss



    (59)



    (63)



    (131)



    (25)

    Interest expense, net



    (19)



    (19)



    (79)



    (79)

    Equity in income of investment in unconsolidated affiliates



    4



    2



    4



    44

    Other income (expense), net



    1



    (1)



    14



    21

    Loss from continuing operations before income taxes



    (73)



    (81)



    (192)



    (39)

    Income tax expense



    (1)



    (29)



    (26)



    (61)

    Loss from continuing operations



    (74)



    (110)



    (218)



    (100)

    Loss from discontinued operations, net of tax



    (8)



    (15)



    (9)



    (27)

    Net loss



    (82)



    (125)



    (227)



    (127)

    Net income attributable to noncontrolling interests



    (14)



    (16)



    (57)



    (62)

    Net loss attributable to Huntsman Corporation



    $        (96)



    $       (141)



    $       (284)



    $       (189)



















    Adjusted EBITDA(1)



    $          35



    $          71



    $        275



    $        414

    Adjusted net loss (1)



    $        (63)



    $        (43)



    $       (121)



    $        (13)



















    Basic loss per share



    $      (0.56)



    $      (0.82)



    $      (1.65)



    $      (1.10)

    Diluted loss per share



    $      (0.56)



    $      (0.82)



    $      (1.65)



    $      (1.10)

    Adjusted diluted loss per share(1)



    $      (0.37)



    $      (0.25)



    $      (0.70)



    $      (0.08)



















    Common share information:

















    Basic weighted average shares



    173



    172



    173



    172

    Diluted weighted average shares



    173



    172



    173



    172

    Diluted shares for adjusted diluted loss per share



    173



    172



    173



    172



















    See end of press release for footnote explanations.

















     

    Table 2 – Results of Operations by Segment 







    Three months ended







    Twelve months ended









    December 31,



    (Worse) /



    December 31,



    (Worse) /

    In millions



    2025



    2024



    better



    2025



    2024



    better



























    Segment revenues:

























    Polyurethanes



    $        897



    $        970



    (8 %)



    $     3,697



    $     3,900



    (5 %)

    Performance Products



    224



    239



    (6 %)



    997



    1,109



    (10 %)

    Advanced Materials



    243



    254



    (4 %)



    1,021



    1,055



    (3 %)

    Total reportable segments' revenues



    1,364



    1,463



    (7 %)



    5,715



    6,064



    (6 %)



























    Intersegment eliminations



    (9)



    (11)



    n/m



    (32)



    (28)



    n/m



























    Total revenues



    $     1,355



    $     1,452



    (7 %)



    $     5,683



    $     6,036



    (6 %)



























    Segment adjusted EBITDA(1):

























    Polyurethanes



    $          25



    $          50



    (50 %)



    $        146



    $        245



    (40 %)

    Performance Products



    16



    23



    (30 %)



    107



    153



    (30 %)

    Advanced Materials



    36



    37



    (3 %)



    161



    179



    (10 %)

    n/m = not meaningful

























    See end of press release for footnote explanations.

























     

    Table 3 – Factors Impacting Sales Revenue



























    Three months ended





    December 31, 2025 vs. 2024





    Average selling price(a)

















    Local



    Exchange



    Sales













    currency & mix



    rate



    volume(b)



    Total



























    Polyurethanes



    (11 %)



    1 %



    2 %



    (8 %)



























    Performance Products



    (6 %)



    1 %



    (1 %)



    (6 %)



























    Advanced Materials



    1 %



    2 %



    (7 %)



    (4 %)



























    Combined segments



    (8 %)



    1 %



    0 %



    (7 %)































    Twelve months ended





    December 31, 2025 vs. 2024





    Average selling price(a)

















    Local



    Exchange



    Sales













    currency & mix



    rate



    volume(b)



    Total



























    Polyurethanes



    (7 %)



    0 %



    2 %



    (5 %)



























    Performance Products



    (1 %)



    0 %



    (9 %)



    (10 %)



























    Advanced Materials



    (2 %)



    1 %



    (2 %)



    (3 %)



























    Combined segments



    (5 %)



    0 %



    (1 %)



    (6 %)



























    (a) Excludes sales from tolling arrangements, by-products and raw materials.













    (b) Excludes sales from by-products and raw materials.

















     

    Table 4 -- Reconciliation of U.S. GAAP to Non-GAAP Measures

















































     Income tax 



     Net 



     Diluted (loss) income 







     EBITDA 



    and other expense



     loss 



     per share 







    Three months ended



    Three months ended



    Three months ended



    Three months ended







    December 31,



    December 31,



    December 31,



    December 31,



    In millions, except per share amounts



    2025



    2024



    2025



    2024



    2025



    2024



    2025



    2024







































    Net loss



    $         (82)



    $       (125)











    $         (82)



    $       (125)



    $      (0.48)



    $      (0.73)



    Net income attributable to noncontrolling interests



    (14)



    (16)











    (14)



    (16)



    (0.08)



    (0.09)







































    Net loss attributable to Huntsman Corporation



    (96)



    (141)











    (96)



    (141)



    (0.56)



    (0.82)



    Interest expense, net from continuing operations



    19



    19



























    Income tax expense from continuing operations



    1



    29



    $           (1)



    $         (29)



















    Income tax benefit from discontinued operations



    (1)



    (3)



























    Depreciation and amortization from continuing operations



    73



    75



























    Business acquisition and integration expenses and purchase accounting inventory adjustments, net



    1



    -



    -



    (1)



    1



    (1)



    0.01



    (0.01)



    EBITDA / Loss from discontinued operations



    9



    18



     N/A 



     N/A 



    8



    15



    0.05



    0.09



    Establishment of significant deferred tax asset valuation allowances, net



    -



    -



    -



    23



    -



    23



    -



    0.13



    Loss on sale of business/assets



    3



    -



    (1)



    (3)



    2



    (3)



    0.01



    (0.02)



    Loss on dissolution of subsidiaries



    -



    39



    -



    -



    -



    39



    -



    0.23



    Fair value adjustments to Venator investment, net and other tax matter adjustments



    -



    -



    -



    1



    -



    1



    -



    0.01



    Certain legal and other settlements and related expenses, net



    2



    -



    -



    (4)



    2



    (4)



    0.01



    (0.02)



    Amortization of pension and postretirement actuarial losses



    12



    14



    -



    (4)



    12



    10



    0.07



    0.06



    Restructuring, impairment and plant closing and transition costs



    12



    21



    (4)



    (3)



    8



    18



    0.05



    0.10







































    Adjusted(1)



    $          35



    $          71



    $           (6)



    $         (20)



    (63)



    (43)



    $      (0.37)



    $      (0.25)







































    Adjusted income tax expense(1)



















    6



    20











    Net income attributable to noncontrolling interests



















    14



    16















































    Adjusted pre-tax loss (1)



















    $         (43)



    $           (7)















































    Adjusted effective tax rate(3)



















    (14 %)



    N/M















































    Effective tax rate



















    (1 %)



    (36 %)



























































     Income tax 



     Net 



     Diluted (loss) income 







     EBITDA 



    and other expense



     loss 



     per share 







    Twelve months ended



    Twelve months ended



    Twelve months ended



    Twelve months ended







    December 31,



    December 31,



    December 31,



    December 31,



    In millions, except per share amounts



    2025



    2024



    2025



    2024



    2025



    2024



    2025



    2024







































    Net loss



    $       (227)



    $       (127)











    $       (227)



    $       (127)



    $      (1.32)



    $      (0.74)



    Net income attributable to noncontrolling interests



    (57)



    (62)











    (57)



    (62)



    (0.33)



    (0.36)







































    Net loss attributable to Huntsman Corporation



    (284)



    (189)











    (284)



    (189)



    (1.65)



    (1.10)



    Interest expense, net from continuing operations



    79



    79



























    Income tax expense from continuing operations



    26



    61



    $         (26)



    $         (61)



















    Income tax benefit from discontinued operations(3)



    -



    (11)



























    Depreciation and amortization from continuing operations



    287



    289



























    Business acquisition and integration (gain) expenses and purchase accounting inventory adjustments



    (4)



    21



    -



    (17)



    (4)



    4



    (0.02)



    0.02



    EBITDA / Loss from discontinued operations(3)



    9



    38



    N/A



    N/A



    9



    27



    0.05



    0.16



    Establishment of significant deferred tax asset valuation allowances, net



    -



    -



    1



    23



    1



    23



    0.01



    0.13



    Income tax settlement related to U.S. Tax Reform Act



    -



    -



    -



    5



    -



    5



    -



    0.03



    Loss on sale of business/assets



    5



    1



    (1)



    -



    4



    1



    0.02



    0.01



    Loss on dissolution of subsidiaries



    -



    39



    -



    -



    -



    39



    -



    0.23



    Fair value adjustments to Venator investment, net and other tax matter adjustments



    -



    (12)



    -



    3



    -



    (9)



    -



    (0.05)



    Certain legal and other settlements and related (income) expenses, net



    (30)



    13



    7



    (3)



    (23)



    10



    (0.13)



    0.06



    Amortization of pension and postretirement actuarial losses



    34



    39



    (4)



    (3)



    30



    36



    0.17



    0.21



    Restructuring, impairment and plant closing and transition costs



    153



    46



    (7)



    (6)



    146



    40



    0.85



    0.23







































    Adjusted(1)



    $        275



    $        414



    $         (30)



    $         (59)



    (121)



    (13)



    $      (0.70)



    $      (0.08)







































    Adjusted income tax expense(1)



















    30



    59











    Net income attributable to noncontrolling interests



















    57



    62















































    Adjusted pre-tax (loss) income(1)



















    $         (34)



    $        108















































    Adjusted effective tax rate(4)



















    (88 %)



    55 %















































    Effective tax rate



















    (14 %)



    (156 %)















































    N/M = not meaningful



































    N/A = not applicable



































    See end of press release for footnote explanations.



































     

    Table 5 – Balance Sheets















    December 31,



    December 31,

    In millions



    2025



    2024











    Cash



    $               429



    $               340

    Accounts and notes receivable, net



    677



    725

    Inventories



    818



    917

    Prepaid expenses



    94



    114

    Other current assets



    46



    29

    Property, plant and equipment, net



    2,486



    2,493

    Other noncurrent assets



    2,465



    2,496











    Total assets



    $            7,015



    $            7,114











    Accounts payable



    $               721



    $               770

    Other current liabilities



    515



    470

    Current portion of debt



    353



    325

    Long-term debt



    1,658



    1,510

    Other noncurrent liabilities



    811



    876

    Huntsman Corporation stockholders' equity



    2,750



    2,959

    Noncontrolling interests in subsidiaries



    207



    204











    Total liabilities and equity



    $            7,015



    $            7,114

     

    Table 6 – Outstanding Debt







    December 31,



    December 31,

    In millions



    2025



    2024











    Debt:









    Revolving credit facility



    $               343



    $                  -

    Senior notes



    1,488



    1,799

    Accounts receivable programs



    152



    -

    Variable interest entities



    7



    16

    Other debt



    21



    20











    Total debt - excluding affiliates



    2,011



    1,835











    Total cash



    429



    340











    Net debt - excluding affiliates(4)



    $            1,582



    $            1,495











    See end of press release for footnote explanations.









     

    Table 7 – Summarized Statements of Cash Flows























    Three months ended



    Twelve months ended





    December 31,



    December 31,

    In millions



    2025



    2024



    2025



    2024



















    Total cash at beginning of period



    $            468



    $            330



    $            340



    $            540



















    Net cash provided by operating activities from continuing operations



    77



    159



    298



    285

    Net cash used in operating activities from discontinued operations



    (1)



    (6)



    (9)



    (22)

    Net cash used in investing activities



    (58)



    (39)



    (132)



    (126)

    Net cash used in financing activities



    (62)



    (95)



    (76)



    (326)

    Effect of exchange rate changes on cash



    5



    (9)



    8



    (11)



















    Total cash at end of period



    $            429



    $            340



    $            429



    $            340



















    Free cash flow from continuing operations(2):

















    Net cash provided by operating activities from continuing operations



    $              77



    $            159



    $            298



    $            285

    Capital expenditures



    (57)



    (51)



    (173)



    (184)



















    Free cash flow from continuing operations(2)



    $              20



    $            108



    $            125



    $            101



















    Supplemental cash flow information:

















    Cash paid for interest



    $             (37)



    $             (22)



    $             (86)



    $             (77)

    Cash paid for income taxes



    (19)



    (30)



    (98)



    (90)

    Cash paid for restructuring and integration



    (11)



    (3)



    (29)



    (29)

    Cash paid for pensions



    (8)



    (9)



    (33)



    (35)

    Depreciation and amortization from continuing operations



    73



    75



    287



    289



















    Change in primary working capital:

















    Accounts and notes receivable



    $              97



    $              79



    $              71



    $                7

    Inventories



    19



    60



    133



    (77)

    Accounts payable



    15



    48



    (88)



    69

    Total change in primary working capital



    $            131



    $            187



    $            116



    $              (1)



















    See end of press release for footnote explanations.

















     

    Footnotes





    (1)

    We use adjusted EBITDA to measure the operating performance of our business and for planning and evaluating the performance of our business segments.  We provide adjusted net income (loss) because we feel it provides meaningful insight for the investment community into the performance of our business.  We believe that net income (loss) is the performance measure calculated and presented in accordance with generally accepted accounting principles in the U.S. ("GAAP") that is most directly comparable to adjusted EBITDA and adjusted net income (loss).  Additional information with respect to our use of each of these financial measures follows:







    Adjusted EBITDA, adjusted net income (loss) and adjusted diluted income (loss) per share, as used herein, are not necessarily comparable to other similarly titled measures of other companies.







    Adjusted EBITDA is computed by eliminating the following from net income (loss):  (a) net income attributable to noncontrolling interests; (b) interest expense, net; (c) income taxes; (d) depreciation and amortization; (e) amortization of pension and postretirement actuarial losses; (f) restructuring, impairment and plant closing and transition costs; and further adjusted for certain other items set forth in the reconciliation of net income (loss) to adjusted EBITDA in Table 4 above. 







    Adjusted net income (loss) and adjusted diluted income (loss) per share are computed by eliminating the after tax impact of the following items from net income (loss): (a) net income attributable to noncontrolling interests; (b) amortization of pension and postretirement actuarial losses; (c) restructuring, impairment and plant closing and transition costs; and further adjusted for certain other items set forth in the reconciliation of net income (loss) to adjusted net income (loss) in Table 4 above.  The income tax impacts, if any, of each adjusting item represent a ratable allocation of the total difference between the unadjusted tax expense and the total adjusted tax expense, computed without consideration of any adjusting items using a with and without approach.







    We may disclose forward-looking adjusted EBITDA because we cannot adequately forecast certain items and events that may or may not impact us in the near future, such as business acquisition and integration expenses and purchase accounting inventory adjustments, net, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted. Each of such adjustment has not yet occurred, is out of our control and/or cannot be reasonably predicted. In our view, our forward-looking adjusted EBITDA represents the forecast net income on our underlying business operations but does not reflect any adjustments related to the items noted above that may occur and can cause our adjusted EBITDA to differ.





    (2)

    We believe free cash flow is an important indicator of our liquidity as it measures the amount of cash we generate. Management internally uses free cash flow measure to: (a) evaluate our liquidity, (b) evaluate strategic investments, (c) plan stock buyback and dividend levels and (d) evaluate our ability to incur and service debt. Free cash flow is defined as net cash provided by (used in) operating activities less capital expenditures. Free cash flow is not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash flow amount is available for discretionary expenditures.





    (3)

    We believe the adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses' operational profitability and that may obscure underlying business results and trends. In our view, effective tax rate is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted effective tax rate. The reconciliation of historical adjusted effective tax rate and effective tax rate is set forth in Table 4 above. Please see the reconciliation of our net income to adjusted net income in Table 4 for details regarding the tax impacts of our non-GAAP adjustments.





    (4)

    Net debt is a measure we use to monitor how much debt we have after taking into account our total cash. We use it as an indicator of our overall financial position, and calculate it by taking our total debt, including the current portion, and subtracting total cash.

    About Huntsman:

    Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2025 revenues of approximately $6 billion from our continuing operations. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 55 manufacturing, R&D and operations facilities in approximately 25 countries and employ approximately 6,000 associates within our continuing operations. For more information about Huntsman, please visit the company's website at www.huntsman.com.

    Social Media:

    X: http://www.x.com/Huntsman_Corp

    Facebook: www.facebook.com/huntsmancorp

    LinkedIn: www.linkedin.com/company/huntsman

    Forward-Looking Statements: 

    This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, divestitures or strategic transactions, business trends and any other information that is not historical information. When used in this press release, the words "estimates," "expects," "anticipates," "likely," "projects," "outlook," "plans," "intends," "believes," "forecasts," or future or conditional verbs, such as "will," "should," "could" or "may," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements, including, without limitation, management's examination of historical operating trends and data, are based upon our current expectations and various assumptions and beliefs. In particular, such forward-looking statements are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the Company's operations, markets, products, prices and other factors as discussed in the Company's filings with the Securities and Exchange Commission (the "SEC"). Significant risks and uncertainties may relate to, but are not limited to, high energy costs in Europe, inflation and high capital costs, geopolitical instability, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, reorganization or restructuring of the Company's operations, including any delay of, or other negative developments affecting the ability to implement cost reductions and manufacturing optimization improvements in the Company's businesses and to realize anticipated cost savings, and other financial, operational, economic, competitive, environmental, political, legal, regulatory and technological factors. Any forward-looking statement should be considered in light of the risks set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025, which may be supplemented by other risks and uncertainties disclosed in any subsequent reports filed or furnished by the Company from time to time. All forward-looking statements apply only as of the date made. Except as required by law, the Company undertakes no obligation to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events.

    Huntsman Corporation Logo (PRNewsfoto/Huntsman Corporation)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/huntsman-announces-fourth-quarter-2025-earnings-302689954.html

    SOURCE Huntsman Corporation

    Get the next $HUN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUN

    DatePrice TargetRatingAnalyst
    10/14/2025$8.00Neutral → Underperform
    BofA Securities
    9/12/2025$9.00Neutral → Underperform
    Mizuho
    5/5/2025$13.00Overweight → Equal Weight
    Wells Fargo
    4/15/2025$15.00Buy → Neutral
    BofA Securities
    1/15/2025Overweight → Neutral
    Alembic Global Advisors
    6/7/2024$22.00 → $27.00Underweight → Overweight
    JP Morgan
    2/23/2024$25.00 → $32.00Equal Weight → Overweight
    Wells Fargo
    12/11/2023$28.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $HUN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Sr. VP, Human Resources Rogers Robert Wade was granted 37,679 shares and covered exercise/tax liability with 4,855 shares, increasing direct ownership by 6% to 541,391 units (SEC Form 4)

    4 - Huntsman CORP (0001307954) (Issuer)

    2/17/26 4:46:11 PM ET
    $HUN
    Major Chemicals
    Industrials

    Division President Wright Scott J was granted 33,911 shares and covered exercise/tax liability with 4,189 shares, increasing direct ownership by 18% to 194,167 units (SEC Form 4)

    4 - Huntsman CORP (0001307954) (Issuer)

    2/17/26 4:45:56 PM ET
    $HUN
    Major Chemicals
    Industrials

    VP & Controller Jorgensen Steven C. was granted 11,304 shares and covered exercise/tax liability with 1,318 shares, increasing direct ownership by 31% to 41,929 units (SEC Form 4)

    4 - Huntsman CORP (0001307954) (Issuer)

    2/17/26 4:45:40 PM ET
    $HUN
    Major Chemicals
    Industrials

    $HUN
    SEC Filings

    View All

    Huntsman Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Huntsman CORP (0001307954) (Filer)

    2/17/26 4:30:43 PM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Huntsman CORP (0001307954) (Filer)

    2/13/26 4:19:14 PM ET
    $HUN
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Huntsman Corporation

    SCHEDULE 13G/A - Huntsman CORP (0001307954) (Subject)

    1/7/26 2:59:06 PM ET
    $HUN
    Major Chemicals
    Industrials

    $HUN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Huntsman downgraded by BofA Securities with a new price target

    BofA Securities downgraded Huntsman from Neutral to Underperform and set a new price target of $8.00

    10/14/25 8:42:01 AM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman downgraded by Mizuho with a new price target

    Mizuho downgraded Huntsman from Neutral to Underperform and set a new price target of $9.00

    9/12/25 7:49:42 AM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Huntsman from Overweight to Equal Weight and set a new price target of $13.00

    5/5/25 8:29:26 AM ET
    $HUN
    Major Chemicals
    Industrials

    $HUN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Exec VP & CFO Lister Philip M. bought $242,709 worth of shares (29,762 units at $8.15), disposed of 49,704 shares and acquired 49,704 shares, decreasing direct ownership by 23% to 67,210 units (SEC Form 4)

    4 - Huntsman CORP (0001307954) (Issuer)

    11/12/25 4:05:54 PM ET
    $HUN
    Major Chemicals
    Industrials

    Chairman, President & CEO Huntsman Peter R bought $503,405 worth of shares (45,000 units at $11.19), increasing direct ownership by 0.69% to 6,600,227 units (SEC Form 4)

    4 - Huntsman CORP (0001307954) (Issuer)

    5/8/25 7:28:03 AM ET
    $HUN
    Major Chemicals
    Industrials

    Chairman, President & CEO Huntsman Peter R bought $492,954 worth of shares (42,000 units at $11.74), increasing direct ownership by 0.64% to 6,555,227 units (SEC Form 4)

    4 - Huntsman CORP (0001307954) (Issuer)

    5/7/25 4:04:39 PM ET
    $HUN
    Major Chemicals
    Industrials

    $HUN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Huntsman Announces First Quarter 2026 Common Dividend and 2026 Annual Meeting of Stockholders

    THE WOODLANDS, Texas, Feb. 17, 2026 /PRNewswire/ -- Huntsman Corporation (NYSE:HUN) announced today that its Board of Directors has declared a $0.0875 per share cash dividend on its common stock. The dividend is payable on March 31, 2026, to stockholders of record as of March 13, 2026.Huntsman Corporation also announced it will hold its 2026 Annual Meeting of Stockholders in virtual meeting format only at 8:00 a.m. Central Time on Wednesday, April 29, 2026. Holders of record as of the close of business on March 6, 2026 will be entitled to vote at the meeting.About Huntsman:Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals wit

    2/17/26 4:20:00 PM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman Announces Fourth Quarter 2025 Earnings

    Fourth Quarter HighlightsFourth quarter 2025 net loss attributable to Huntsman of $96 million compared to a net loss of $141 million in the prior year period; fourth quarter 2025 diluted loss per share of $0.56 compared to diluted loss per share $0.82 in the prior year period.Fourth quarter 2025 adjusted net loss attributable to Huntsman of $63 million compared to adjusted net loss of $43 million in the prior year period; fourth quarter 2025 adjusted diluted loss per share of $0.37 compared to adjusted diluted loss per share of $0.25 in the prior year period.Fourth quarter 2025 adjusted EBITDA of $35 million compared to $71 million in the prior year period.Fourth quarter 2025 net cash provid

    2/17/26 4:15:00 PM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman to Discuss Fourth Quarter 2025 Results on February 18, 2026

    THE WOODLANDS, Texas, Jan. 7, 2026 /PRNewswire/ -- Huntsman Corporation (NYSE:HUN) will hold a conference call on Wednesday, February 18, 2026, at 10:00 a.m. ET to discuss its fourth quarter 2025 financial results. Following some opening remarks, the call will move into a question and answer session. The earnings press release, including financial statements and segment information, will be distributed after the market closes on Tuesday, February 17, 2026. The earnings slide presentation and prepared remarks will be available at www.huntsman.com/investors after the market closes on Tuesday, February 17, 2026. Webcast link:https://event.choruscall.com/mediaframe/webcast.html?webcastid=IMeg0PN

    1/7/26 4:15:00 PM ET
    $HUN
    Major Chemicals
    Industrials

    $HUN
    Financials

    Live finance-specific insights

    View All

    Huntsman Announces First Quarter 2026 Common Dividend and 2026 Annual Meeting of Stockholders

    THE WOODLANDS, Texas, Feb. 17, 2026 /PRNewswire/ -- Huntsman Corporation (NYSE:HUN) announced today that its Board of Directors has declared a $0.0875 per share cash dividend on its common stock. The dividend is payable on March 31, 2026, to stockholders of record as of March 13, 2026.Huntsman Corporation also announced it will hold its 2026 Annual Meeting of Stockholders in virtual meeting format only at 8:00 a.m. Central Time on Wednesday, April 29, 2026. Holders of record as of the close of business on March 6, 2026 will be entitled to vote at the meeting.About Huntsman:Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals wit

    2/17/26 4:20:00 PM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman Announces Fourth Quarter 2025 Earnings

    Fourth Quarter HighlightsFourth quarter 2025 net loss attributable to Huntsman of $96 million compared to a net loss of $141 million in the prior year period; fourth quarter 2025 diluted loss per share of $0.56 compared to diluted loss per share $0.82 in the prior year period.Fourth quarter 2025 adjusted net loss attributable to Huntsman of $63 million compared to adjusted net loss of $43 million in the prior year period; fourth quarter 2025 adjusted diluted loss per share of $0.37 compared to adjusted diluted loss per share of $0.25 in the prior year period.Fourth quarter 2025 adjusted EBITDA of $35 million compared to $71 million in the prior year period.Fourth quarter 2025 net cash provid

    2/17/26 4:15:00 PM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman to Discuss Fourth Quarter 2025 Results on February 18, 2026

    THE WOODLANDS, Texas, Jan. 7, 2026 /PRNewswire/ -- Huntsman Corporation (NYSE:HUN) will hold a conference call on Wednesday, February 18, 2026, at 10:00 a.m. ET to discuss its fourth quarter 2025 financial results. Following some opening remarks, the call will move into a question and answer session. The earnings press release, including financial statements and segment information, will be distributed after the market closes on Tuesday, February 17, 2026. The earnings slide presentation and prepared remarks will be available at www.huntsman.com/investors after the market closes on Tuesday, February 17, 2026. Webcast link:https://event.choruscall.com/mediaframe/webcast.html?webcastid=IMeg0PN

    1/7/26 4:15:00 PM ET
    $HUN
    Major Chemicals
    Industrials

    $HUN
    Leadership Updates

    Live Leadership Updates

    View All

    Huntsman Corporation Appoints Amy Smedley as Executive Vice President, General Counsel & Secretary

    THE WOODLANDS, Texas, Dec. 29, 2025 /PRNewswire/ -- Huntsman Corporation (NYSE:HUN) announced that Amy Smedley has joined the company as Executive Vice President, General Counsel & Secretary effective Jan. 5, 2026. Ms. Smedley will succeed Huntsman's current General Counsel, David Stryker, who is retiring. Ms. Smedley has extensive experience in litigation, compliance, and corporate governance. Most recently, she has served as Executive Vice President and Chief Legal Officer at Savage Companies since 2022. Prior to joining Savage Companies, Ms. Smedley spent 16 years at Huntsman, where she built a successful career as an essential member of the Legal team. With Huntsman, she advanced through

    12/29/25 4:33:00 PM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman Announces Retirement of David Stryker and Appoints Julia Wright as Executive Vice President, General Counsel and Secretary

    THE WOODLANDS, Texas, Sept. 4, 2025 /PRNewswire/ -- Huntsman Corporation (NYSE:HUN) announced today that Julia Wright will join Huntsman as Executive Vice President, General Counsel and Secretary effective on October 13, 2025. Ms. Wright will succeed Huntsman's current General Counsel, David Stryker, who has announced his retirement effective at the end of the year. Mr. Stryker will move into the Chairman's Office to serve as Executive Vice President, Strategic Initiatives, pending his retirement. Ms. Wright has over 15 years of senior executive experience, most recently at ChampionX Corporation, a global leader in chemistry solutions, artificial lift systems, and highly engineered equipment

    9/4/25 4:45:00 PM ET
    $HUN
    Major Chemicals
    Industrials

    Huntsman Chairman and CEO Issues Open Letter to Shareholders

    Emphasizes successful execution of strategic plan, historic results and 5-Year TSR of 91%1, substantial progress achieving 2022-2024 targets Highlights fully refreshed and fit for purpose Board holding management accountable Urges Shareholders to Vote "FOR ALL" of Huntsman's Highly Qualified Director Nominees on the WHITE Proxy Card THE WOODLANDS, Texas, March 16, 2022 /PRNewswire/ -- Peter R. Huntsman, Chairman of the Board of Directors of Huntsman Corporation (NYSE:HUN), issued the following letter to all Huntsman's shareholders in advance of its upcoming 2022 Annual Meeting of Stockholders, scheduled to be held on March 25, 2022: Dear Fellow Shareholders, We're less than 10 days away

    3/16/22 7:00:00 AM ET
    $HUN
    Major Chemicals
    Industrials

    $HUN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Huntsman Corporation (Amendment)

    SC 13G/A - Huntsman CORP (0001307954) (Subject)

    2/13/24 5:06:19 PM ET
    $HUN
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Huntsman Corporation (Amendment)

    SC 13G/A - Huntsman CORP (0001307954) (Subject)

    4/10/23 1:39:59 PM ET
    $HUN
    Major Chemicals
    Industrials

    SEC Form SC 13D/A filed by Huntsman Corporation (Amendment)

    SC 13D/A - Huntsman CORP (0001307954) (Subject)

    5/19/22 5:21:28 PM ET
    $HUN
    Major Chemicals
    Industrials